Abstract

Continuing our research aimed at obtaining new compounds with high affinity and selectivity toward α1-AR, a new series of arylpiperazine derivatives was designed, synthesized, and biologically tested. The new compounds 1–17 are characterized by a phenylphthalazin-1(2H)-one fragment connected through an alkyl chain to an arylpiperazine residue. The pharmacological profile of these compounds was evaluated for their affinity and selectivity toward α1-AR, α2-AR and toward 5HT1A serotoninergic receptor. A discussion on the structure–activity relationship (SAR) of these compounds is also reported.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.